Sotera Health (NASDAQ:SHC) Shares Sold by ExodusPoint Capital Management LP

ExodusPoint Capital Management LP lowered its stake in Sotera Health (NASDAQ:SHC) by 38.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 1,338,819 shares of the company’s stock after selling 839,247 shares during the quarter. ExodusPoint Capital Management LP’s holdings in Sotera Health were worth $18,315,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Xponance Inc. grew its position in shares of Sotera Health by 6.0% in the fourth quarter. Xponance Inc. now owns 17,495 shares of the company’s stock valued at $239,000 after purchasing an additional 989 shares during the period. Wealth Enhancement Advisory Services LLC lifted its stake in Sotera Health by 2.1% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 51,940 shares of the company’s stock valued at $711,000 after buying an additional 1,047 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Sotera Health by 37.5% in the 4th quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock worth $56,000 after buying an additional 1,121 shares during the last quarter. Blue Trust Inc. increased its stake in Sotera Health by 164.3% during the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock worth $25,000 after buying an additional 1,140 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. raised its holdings in shares of Sotera Health by 17.3% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 15,839 shares of the company’s stock valued at $217,000 after acquiring an additional 2,340 shares during the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Stock Performance

Shares of Sotera Health stock opened at $10.73 on Friday. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The business’s 50 day moving average price is $12.67 and its 200 day moving average price is $13.87. The company has a market cap of $3.04 billion, a price-to-earnings ratio of 42.92 and a beta of 1.92. Sotera Health has a one year low of $9.00 and a one year high of $17.08.

Wall Street Analysts Forecast Growth

SHC has been the subject of several research reports. Barclays dropped their price target on Sotera Health from $17.00 to $16.00 and set an “overweight” rating for the company in a research report on Friday, February 28th. The Goldman Sachs Group began coverage on shares of Sotera Health in a research report on Friday, December 6th. They issued a “neutral” rating and a $14.00 target price for the company. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $16.00.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.